Qiagen NV Valuation
| QGEN Stock | USD 39.82 0.34 0.86% |
At this time, the company appears to be undervalued. Qiagen NV holds a recent Real Value of $46.19 per share. The prevailing price of the company is $39.82. Our model determines the value of Qiagen NV from analyzing the company fundamentals such as Return On Equity of 0.0227, shares outstanding of 216.12 M, and Operating Margin of 0.28 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Qiagen NV's valuation include:
Price Book 2.3918 | Enterprise Value | Enterprise Value Ebitda 23.8171 | Price Sales 4.3131 | Forward PE 16.5837 |
Undervalued
Today
Please note that Qiagen NV's price fluctuation is very steady at this time. Calculation of the real value of Qiagen NV is based on 3 months time horizon. Increasing Qiagen NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Qiagen NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Qiagen Stock. However, Qiagen NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.82 | Real 46.19 | Target 51.14 | Hype 39.76 |
The intrinsic value of Qiagen NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Qiagen NV's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Qiagen NV helps investors to forecast how Qiagen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Qiagen NV more accurately as focusing exclusively on Qiagen NV's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Qiagen NV's intrinsic value based on its ongoing forecasts of Qiagen NV's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Qiagen NV's closest peers.
Qiagen NV Cash |
|
Qiagen Valuation Trend
Knowing Qiagen NV's actual value is paramount for traders when making sound investment determinations. Using both Qiagen NV's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Qiagen NV Total Value Analysis
Qiagen NV is at this time forecasted to have valuation of 8.77 B with market capitalization of 8.53 B, debt of 1.39 B, and cash on hands of 1.89 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Qiagen NV fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.77 B | 8.53 B | 1.39 B | 1.89 B |
Qiagen NV Investor Information
About 64.0% of the company shares are owned by institutional investors. The book value of Qiagen NV was at this time reported as 16.05. The company has Price/Earnings To Growth (PEG) ratio of 0.91. Qiagen NV last dividend was issued on the 29th of January 2025. The entity had 962:1000 split on the 25th of January 2017. Based on the key indicators related to Qiagen NV's liquidity, profitability, solvency, and operating efficiency, Qiagen NV may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0469 | 0.0494 |
|
| |||||
| Total Cash From Operating Activities | 707.2 M | 673.6 M |
|
| |||||
| Operating Income | 180.4 M | 97.7 M |
|
|
Qiagen NV Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Qiagen NV has an asset utilization ratio of 34.77 percent. This suggests that the Company is making $0.35 for each dollar of assets. An increasing asset utilization means that Qiagen NV is more efficient with each dollar of assets it utilizes for everyday operations.Qiagen NV Ownership Allocation
Qiagen NV owns a total of 216.12 Million outstanding shares. Over half of Qiagen NV's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. On April 3, 2020, Representative Peter Welch of US Congress acquired under $15k worth of Qiagen NV's common stock.Qiagen NV Profitability Analysis
The company reported the previous year's revenue of 1.98 B. Net Income was 83.59 M with profit before overhead, payroll, taxes, and interest of 1.32 B.About Qiagen NV Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Qiagen NV. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Qiagen NV based exclusively on its fundamental and basic technical indicators. By analyzing Qiagen NV's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Qiagen NV's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Qiagen NV. We calculate exposure to Qiagen NV's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Qiagen NV's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.3 B | 690.4 M | |
| Pretax Profit Margin | 0.06 | 0.06 | |
| Operating Profit Margin | 0.05 | 0.05 | |
| Net Profit Margin | 0.04 | 0.04 | |
| Gross Profit Margin | 0.67 | 0.75 |
Qiagen NV Quarterly Retained Earnings |
|
Qiagen NV Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 224.7 M | |
| Quarterly Earnings Growth Y O Y | -0.099 | |
| Forward Price Earnings | 16.5837 |
Qiagen NV Current Valuation Indicators
Qiagen NV's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Qiagen NV's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Qiagen NV, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Qiagen NV's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Qiagen NV's worth.When determining whether Qiagen NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qiagen NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.1) | Earnings Share 0.38 | Revenue Per Share | Quarterly Revenue Growth 0.024 | Return On Assets |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.